IDXG首席执行官Thomas Burnell表示,随着交易的完成,公司的运营现金流预计每年将增加近500万美元,且将把出售所得用于满足营运资金需求,并用于投资发展分子诊断业务。
$药明康德(SH603259)$ $泰格医药(SZ...查看全文
不乱下2019-04-25 11:27
$Interpace诊断(IDXG)$ 从事于美国甲状腺癌/胰腺癌组织LDT基因诊断服务(不是液体活检),这是一家LDT服务商。 IDXG的主要产品都是并购过来的资产,所以这家公司的定位就是一个商业化公司而不是一个技术公司。 按照公司的说法,公司在甲状腺癌组织基因诊断服务方面技术上还是领先的,而胰腺癌好像...查看全文
$Interpace Diagnostics(IDXG)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-01-10 AccNo: 0000892712-17-000016 Size: 56 KB 网页链接
$Interpace Diagnostics(IDXG)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-01-09 AccNo: 0001535610-17-000031 Size: 13 KB 网页链接
$Interpace Diagnostics(IDXG)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-01-09 AccNo: 0000902664-17-000072 Size: 81 KB 网页链接
$Interpace Diagnostics(IDXG)$ 8-K - Current report Filed: 2017-01-06 AccNo: 0001437749-17-000289 Size: 62 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Interpace Diagnostics(IDXG)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-01-05 AccNo: 0001437749-17-000273 Size: 514 KB 网页链接
$Interpace Diagnostics(IDXG)$ 8-K/A [Amend] - Current report Filed: 2017-01-05 AccNo: 0001437749-17-000272 Size: 171 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Interpace Diagnostics(IDXG)$ 8-K - Current report Filed: 2017-01-03 AccNo: 0001437749-17-000033 Size: 605 KBItem 1.01: Entry into a Material Definitive AgreementItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Interpace Diagnostics(IDXG)$ 8-K - Current report Filed: 2016-12-28 AccNo: 0001437749-16-043860 Size: 81 KBItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 8.01: Other Event...
$Interpace Diagnostics(IDXG)$ 8-K - Current report Filed: 2016-12-21 AccNo: 0001437749-16-043661 Size: 62 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Interpace Diagnostics(IDXG)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-12-19 AccNo: 0001535610-16-000172 Size: 13 KB 网页链接